Coronary Microvascular Disease Early After Myocardial Infarction: Diagnostic Approach and Prognostic Value-A Narrative Review
- PMID: 40564009
- PMCID: PMC12189317
- DOI: 10.3390/biomedicines13061289
Coronary Microvascular Disease Early After Myocardial Infarction: Diagnostic Approach and Prognostic Value-A Narrative Review
Abstract
Coronary microvascular disease (CMVD) is not an uncommon complication after acute myocardial infarction (AMI), independent of prompt revascularization. It is a serious yet underdiagnosed disease that has a major impact on patient outcomes. Even when the infarct-related artery is successfully revascularized, a significant percentage of patients still have compromised microvascular circulation, which is linked to higher cardiovascular mortality and hospitalization for heart failure. The well-known invasive methods, such as the index of microvascular resistance (IMR) and the coronary flow reserve (CFR), have been considered as gold standards. However, they are constrained by their hazards and complexity. Non-invasive techniques, such as echocardiography Doppler for CFR assessment, positron emission tomography (PET), cardiac magnetic resonance imaging (CMR), and some other techniques provide alternatives, but their accessibility, cost and implementation during the peri-AMI period raise obstacles to their wider use. This review highlights both invasive and non-invasive modalities as it examines the diagnostic methods and prognostic significance of CMVD development early after AMI. Enhancing long-term results in this high-risk population requires a thorough understanding of pathophysiology and a commitment to larger diagnostic and prognostic studies for CMVD.
Keywords: acute myocardial infarction (AMI); coronary flow reserve (CFR); coronary microvascular disease (CMVD); index of microcirculatory resistance (IMR); major adverse cardiovascular events (MACE); microvascular obstruction (MVO); percutaneous coronary intervention (PCI).
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Kunadian V., Chieffo A., Camici P.G., Berry C., Escaned J., Maas A.H.E.M., Prescott E., Karam N., Appelman Y., Fraccaro C., et al. An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. Eur. Heart J. 2020;41:3504–3520. doi: 10.1093/eurheartj/ehaa503. - DOI - PMC - PubMed
-
- Saad M., Stiermaier T., Fuernau G., Pöss J., De Waha-Thiele S., Desch S., Thiele H., Eitel I. Impact of Direct Stenting on Myocardial Injury Assessed by Cardiac Magnetic Resonance Imaging and Prognosis in ST-Elevation Myocardial Infarction. Int. J. Cardiol. 2019;283:88–92. doi: 10.1016/j.ijcard.2018.11.141. - DOI - PubMed
-
- Feng C., Abdu F.A., Mohammed A.-Q., Zhang W., Liu L., Yin G., Feng Y., Mohammed A.A., Mareai R.M., Lv X., et al. Prognostic Impact of Coronary Microvascular Dysfunction Assessed by caIMR in Overweight with Chronic Coronary Syndrome Patients. Front. Endocrinol. 2022;13:922264. doi: 10.3389/fendo.2022.922264. - DOI - PMC - PubMed
-
- Pries A.R., Badimon L., Bugiardini R., Camici P.G., Dorobantu M., Duncker D.J., Escaned J., Koller A., Piek J.J., De Wit C. Coronary Vascular Regulation, Remodelling, and Collateralization: Mechanisms and Clinical Implications on Behalf of the Working Group on Coronary Pathophysiology and Microcirculation. Eur. Heart J. 2015;36:3134–3146. doi: 10.1093/eurheartj/ehv100. - DOI - PubMed
-
- Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review|JACC. [(accessed on 31 March 2025)]. Available online: https://www.jacc.org/doi/10.1016/j.jacc.2018.09.042. - DOI
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
